期刊文献+

1′-碘代二茂铁甲醛肟酯的设计与合成 被引量:1

Design,Synthesis and Crystal Structure of 1'-Iodoferrocenecarbaldehyde Oxime Esters
下载PDF
导出
摘要 以含多功能团的1′-碘代二茂铁甲醛为起始原料,设计合成了4种1′-碘代二茂铁甲醛肟酯类化合物3a~3d,并用IR,1H NMR,MS和元素分析对其结构进行了确认,其中化合物3a的单晶结构经X射线单晶衍射确证其属单斜晶系(Monoclinic),P2(1)/n空间群,晶胞参数:a=0.6328(3)nm,b=1.0634(7)nm,c=2.3815(13)nm,α=90°,β=93.546(19)°,γ=90°,Z=4,μ=2.883mm-1,Dc=1.910g/cm3,F(000)=896.晶胞堆积图证明化合物3a的分子之间通过电子的授受作用、π-π堆积和氢键等弱相互作用组装成三维四方形管状空穴结构.这种空穴结构可以选择性地对客体分子进行识别. The multi-functional 1′-iodoferrocenecarbaldehyde is a versatile building block in organic synthesis. Four novel 1′-iodoferrocenecarbaldehyde oxime esters were designed and synthesized on the basis of 1′-iodoferrocenecarbaldehyde. The compounds were confirmed by means of elemental analysis, IR spectrum, 1H NMR, MS and X-ray single-crystal diffraction analysis. The crystal of compound 3a belongs to a monoclinic system, space group P2( 1 )/n with cell parameters a =0. 6328(3) nm, b = 1. 0634(7) nm, c = 2.3815(13) nm, α=90°, β=93.546(19)°, γ =90°, Z=4,μ =2.883 mm-1, Dc =1.910 g/cm3, F(000) =896. The crystal structure of compound 3a shows that the molecules can form three-dimension supramolecular cavity assemblies via hydrogen bond, static interaction and aromatic π-π stacking interactions. This special assemblies could selectively recognise some of the guest molecules.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2010年第1期79-83,共5页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:20772016) 留学回国人员科研启动基金 福州大学光催化省部共建国家重点实验室培育基地开放课题(批准号:K-081009)资助
关键词 二茂铁甲醛肟 Π-Π堆积 氢键 自组装 Ferrocenecarbaldehyde oxime or-or Stacking interaction Hydrogen bond Self-assembly
  • 相关文献

参考文献15

二级参考文献46

共引文献71

同被引文献15

  • 1Trofimov B. A. , Nedolya N. A.. Comprehensive Heterocyclic Chemistry III[M]. Oxford: Elsevier, 2008 : 45- 78.
  • 2ChandraT. , Garg N. , LataS. , Saxena K. K., Kumar A.. Eur. J. Med. Chem. [J].2010, 45(5): 1772- 1776.
  • 3GongZ. L., ZhengL. W., ZhaoB. X., YangD. Z., LvH. S., LiuW. Y., LianS.. J. Photoch. Photobio. A: Chem.[J],2010, 209(1): 49 -55.
  • 4Gulhan T. Z. , Pierre C. ,Fatma S. K. , Kevser E.. Eur. J. Ned. Chem.[J].2000, 35(6) : 635-641.
  • 5Stepnicka P.. Ferrocenes: Ligands, Materials and Biomoleeules[ M], Chichester: John Wiley & Sons, 2008:670.
  • 6van Staveren D. R. , Metzler-Nolte N.. Chem. Rev. [J]. 2004, 104(12): 5931-5985.
  • 7Pan X. H., Liu X., ZhaoB. X., Xie Y. S., Shin D. S., ZhangS. L., Zhao J., Miao J. Y.. Bioorg. Med. Chem. [J]. 2008, 16(24) : 9093-9100.
  • 8Pagliero R. J. , Pierini A. B. , Bran R. , Mazzieri M. R.. Lett. Drug. Design Discovery[J] , 2010, 7(6) : 461-470.
  • 9Pagliero R. J. , Lusvarghi S. , Pierini A. B. , Brun R. , Mazzieri M. R.. Bioorg. Med. Chem. [J]. 2010, 18(1 ) : 142- 150.
  • 10Sheldriek G. M.. Acta Cryst.[J].2008, 64(1): 112 -122.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部